Упрощенная HTML-версия
166
87. Nabeshima K. Effect of salt restriction on preeclampsia [article in Japanese]. Nippon Jinzo
Gakkai Shi 1994;36:227-32.
88. Hamlin RH. The prevention of eclampsia and pre-eclampsia. Lancet 1952;1:64-8.
89. Meher S, Abalos E, Carroli G. Bed rest with or without hospitalisation for hypertension during
pregnancy. Cochrane.Database Syst.Rev. 2005;CD003514.
90. Greer IA. Epidemiology, risk factors and prophylaxis of venous thrombo-embolism in
obstetrics and gynaecology. Baillieres Clin Obstet Gynaecol. 1997;11:403-30.
91. Maloni JA, Chance B, Zhang C, Cohen AW, Betts D, Gange SJ. Physical and psychosocial side
effects of antepartum hospital bed rest. Nurs.Res 1993;42:197-203.
92. Mathews DD, Agarwal V, Shuttleworth TP. A randomized controlled trial of complete bed rest
vs ambulation in the management of proteinuric hypertension during pregnancy. Br J Obstet
Gynaecol 1982;89:131.
93. Crowther CA, Bouwmeester AM, Ashurst HM. Does admission to hospital for bed rest prevent
disease progression or improve fetal outcome in pregnancy complicated by non-proteinuric
hypertension? Br J Obstet Gynaecol 1992;99:13-7.
94. Leung KY, Sum TK, Tse CY, Law KW, Chan MY. Is in-patient management of diastolic blood
pressure between 90 and 100 mm Hg during pregnancy necessary? Hong Kong Med J
1998;4:211-7.
95. Mathews DD. A randomized controlled trial of bed rest and sedation or normal activity and
non-sedation in the management of non-albuminuric hypertension in late pregnancy. Br J
Obstet Gynaecol 1977;84:114.
96. Abalos E, Duley L, Steyn D, Henderson-Smart D. Antihypertensive drug therapy for mild to
moderate hypertension during pregnancy. Cochrane Database Syst Rev 2007;CD002252.
97. von Dadelszen P, Magee LA. Fall in mean arterial pressure and fetal growth restriction in
pregnancy hypertension: an updated metaregression analysis. JOGC 2002;24:941-5.
98. von Dadelszen P, Ornstein MP, Bull SB, Logan AG, Koren G, Magee LA. Fall in mean arterial
pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet
2000;355:87-92.
99. Cockburn J, Moar VA, Ounsted M, Redman CW. Final report of study on hypertension during
pregnancy: the effects of specific treatment on the growth and development of the children.
Lancet 1982;1:647-9.
100.
Reynolds B, Butters L, Evans J, Adams T, Rubin PC. First year of life after the use of atenolol
in pregnancy associated hypertension. Arch Dis Child 1984;59:1061-3.
101.
Bortolus R, Ricci E, Chatenoud L, Parazzini F. Nifedipine administered in pregnancy: effect on
the development of children at 18 months. Br J Obstet Gynaecol 2000;107:792-4.
102.
Caetano M, Ornstein M, von Dadelszen P, Hannah ME, Logan AG, Gruslin A, et al. A survey of
Canadian practitioners regarding the management of the hypertensive disorders of
pregnancy. Hypertens Pregnancy 2003;23:61-74.
103.
Magee LA, Cham C, Waterman EJ, Ohlsson A, von Dadelszen P. Hydralazine for treatment of
severe hypertension in pregnancy: meta-analysis. BMJ 2003;327:955-60.
104.
Magee LA, Miremadi S, Li J, Cheng C, Ensom MH, Carleton B, et al. Therapy with both
magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related
maternal side effects in women with preeclampsia. Am J Obstet Gynecol 2005;193:153-63.
105.
Duley L, Henderson-Smart D. Magnesium sulphate versus diazepam for eclampsia. Cochrane
Database Syst Rev 2000;CD000127.
106.
Duley L, Henderson-Smart D. Magnesium sulphate versus phenytoin for eclampsia. Cochrane
Database Syst Rev 2003;CD000128.
107.
Alexander JM, McIntire DD, Leveno KJ, Cunningham FG. Selective magnesium sulfate
prophylaxis for the prevention of eclampsia in women with gestational hypertension. Obstet
Gynecol 2006;108:826-32.
108.
Li H, Gudmundsson S, Olofsson P. Prospect for vaginal delivery of growth restricted fetuses
with abnormal umbilical artery blood flow. Acta Obstet Gynecol Scand 2003;82:828-33.
109.
Skinner J, Greene RA, Gardeil F, Stuart B, Turner MJ. Does increased resistance on umbilical
artery Doppler preclude a trial of labour? Eur J Obstet Gynecol Reprod Biol 1998;79:35-8.
110.
Weiss E, Ulrich S, Berle P. Condition at birth of infants with previously absent or reverse
umbilical artery end-diastolic flow velocities. Arch Gynecol Obstet 1992;252:37-43.
111.
Tuffnell DJ, Jankowicz D, Lindow SW, Lyons G, Mason GC, Russell IF, et al. Outcomes of
severe pre-eclampsia/eclampsia in Yorkshire 1999/2003. BJOG 2005;112:875-80.